Petee International Completes Series C Financing of Hundreds of Millions of RMB to Lead High-Quality Specialized Veterinary Care
On December 3, Pet International, a leading domestic chain service provider of high-quality pet healthcare, announced the completion of its Series C financing, raising hundreds of millions of RMB. The round was led by a well-known international private equity firm, with Taihe Capital serving as the exclusive financial advisor. The proceeds will be used to build directly operated hospitals in first-tier cities across China, expand and provide continuous training for its pet healthcare talent team, and strengthen the company’s advantages in specialized veterinary medicine and the diagnosis and treatment of critical illnesses.
Pet International, established in 2013, is dedicated to providing high-quality veterinary medical services. It has currently opened dozens of flagship central hospitals and specialized veterinary hospitals across China, covering multiple cities including Beijing, Shanghai, Hangzhou, and Chongqing. Since its inception, it has successfully treated over one million cases. The company innovatively constructs a “Flagship Center + Specialized Hospital” service network using the “Hub-Spoke/1+N” model to achieve comprehensive coverage across different service radii and multiple specialty disciplines.
Pet International has precisely capitalized on the structural opportunities in pet healthcare driven by the aging pet population. With an average lifespan less than one-fifth that of humans, cats and dogs enter their middle-to-senior years after the age of seven. As their physiological functions gradually decline, medical needs will shift from routine preventive care, such as deworming and vaccinations, to specialized diagnostic and treatment services for complex conditions, including oncology and chronic diseases.
In 2020, the number of pet dogs and cats in China exceeded 100 million. With the accelerated growth in pet ownership in recent years and the increasingly pronounced anthropomorphism of pets, coupled with the characteristics of pet life cycles, China’s pet medical services market is poised to experience its first wave of concentrated demand for geriatric care over the next three to five years. Diseases affecting aging animals tend to be more severe and often involve multiple comorbidities. Unlike most community clinics that lack the necessary equipment and specialized personnel, Pet International has established robust capabilities for managing complex cases and developed comprehensive solutions to meet the needs of the new generation of pet owners.
In terms of building a medical-grade talent pool and investing in technology, the Beijing Pet International team has assembled elite experts from both China and abroad, all of whom graduated with degrees in veterinary medicine from renowned domestic and international institutions such as China Agricultural University, Nanjing Agricultural University, Zhejiang University, and Seoul National University. To ensure sustained development, the company conducts regular internal training and engages in technical exchanges with top-tier medical institutions in Japan, South Korea, the United States, and other countries, thereby establishing multidimensional support for specialized clinical medical services and disciplinary development.
The operation of veterinary hospitals requires equal emphasis on technical expertise and service quality. Over the past eight years since its establishment, Pet International has continuously strengthened its middle-office capabilities, refining three core components—talent training, internal operational SOPs, and brand promotion—into standardized modules to support the company’s nationwide business expansion. In terms of technical control, the company prioritizes medical talent reserves as the foundation for expansion, ensuring rigorous management across all medical processes and maintaining key medical indicators above the industry average. Regarding service experience, store designs are centered around pet patients, featuring separate triage and hospitalization areas for cats and dogs, along with differentiated consultation workflows, thereby cultivating excellent user reputation and brand recognition among consumers.
In 2019, Pet International invested tens of millions of yuan to establish a 2,000-square-meter flagship medical center, aiming to create a “Tier-3 Pet Hospital”—a comprehensive veterinary facility integrating medical care, scientific research, teaching, preventive healthcare, and rehabilitation. It fully covers 15 major centers and 25 specialized departments, providing more professional solutions for complex and challenging pet diseases. Currently, approximately 90% of Pet International’s revenue comes from diagnostic and treatment services, with 85% derived from specialized and critical illness treatments. The company has established a competitive barrier in pet healthcare services through its mature team of specialized professionals and advanced equipment.
Commenting on the success of this funding round, Ms. Li Xue, Founder and CEO of Pet International, stated: “Pet International will continue to deepen its focus on specialized veterinary care and will not enter the competitive landscape of community clinics. On one hand, the community clinic sector is already relatively saturated, making it difficult to achieve profitability. Furthermore, from an industry perspective and development trend, analogous to the human healthcare market, the sector will inevitably undergo a process of ‘brand stratification.’ In the future, in addition to continuing to build core barriers within our specialized veterinary chain operation model, Pet International will strategically focus on the ecosystem of the pet healthcare industry. We aim to consolidate and export our medical diagnostic standards, talent training standards, and more, collaborating with industry partners to empower them and drive the rapid growth of the RMB 100 billion pet healthcare market.”